Cargando…

Anti-Double-Stranded DNA Isotypes and Anti-C1q Antibody Improve the Diagnostic Specificity of Systemic Lupus Erythematosus

OBJECTIVES: We aimed to evaluate the value of immunoglobulin (Ig) G, IgM, and IgA isotypes of anti-double-stranded DNA (anti-dsDNA) and anti-C1q antibody in diagnosing systemic lupus erythematosus (SLE) patients and elucidate their association with disease activity and lupus nephritis. METHODS: Bloo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jia, Yu, Zhao, Lingling, Wang, Chunyan, Shang, Jin, Miao, Yi, Dong, Yangyang, Zhao, Zhanzheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180986/ https://www.ncbi.nlm.nih.gov/pubmed/30363714 http://dx.doi.org/10.1155/2018/4528547

Ejemplares similares

Performance Characteristics of Different Anti-Double-Stranded DNA Antibody Assays in the Monitoring of Systemic Lupus Erythematosus
por: Mahler, Michael, et al.
Publicado: (2017)

Is closer linkage between systemic lupus erythematosus and anti-double-stranded DNA antibodies a desirable and attainable goal?
por: Nossent, Hans C, et al.
Publicado: (2005)

Anti‐dsDNA, anti‐nucleosome, anti‐C1q, and anti‐histone antibodies as markers of active lupus nephritis and systemic lupus erythematosus disease activity
por: Shang, Xiaoying, et al.
Publicado: (2021)

Periodontitis is associated with disease severity and anti-double stranded DNA antibody and interferon-gamma levels in patients with systemic lupus erythematosus
por: Gofur, Nanda R.P., et al.
Publicado: (2019)

Value of combined detection of anti-nuclear antibody, anti-double-stranded DNA antibody and C3, C4 complements in the clinical diagnosis of systemic lupus erythematosus
por: Qu, Changhua, et al.
Publicado: (2019)

Anti-dsDNA Antibody Isotypes in Systemic Lupus Erythematosus: IgA in Addition to IgG Anti-dsDNA Help to Identify Glomerulonephritis and Active Disease
por: Villalta, Danilo, et al.
Publicado: (2013)

Efficacy and Safety of Subcutaneous Belimumab in Anti–Double‐Stranded DNA–Positive, Hypocomplementemic Patients With Systemic Lupus Erythematosus
por: Doria, A., et al.
Publicado: (2018)

Anti-IL-10 antibody in systemic lupus erythematosus
por: Uchida, Marina, et al.
Publicado: (2019)

Anti-C1q antibodies antedate patent active glomerulonephritis in patients with systemic lupus erythematosus
por: Meyer, Olivier C, et al.
Publicado: (2009)

Anti-C1q antibodies and their association with complement components in Indian systemic lupus erythematosus patients
por: Pradhan, V., et al.
Publicado: (2012)

Anti-dsDNA Antibodies are one of the many autoantibodies in systemic lupus erythematosus
por: Fu, Shu Man, et al.
Publicado: (2015)

Anti-Sm antibodies in the classification criteria of systemic lupus erythematosus
por: van Beers, Joyce J.B.C., et al.
Publicado: (2022)

An Emerging Role for Anti-DNA Antibodies in Systemic Lupus Erythematosus
por: Kubota, Tetsuo
Publicado: (2023)

Cell-bound complement activation products in systemic lupus erythematosus: comparison with anti-double-stranded DNA and standard complement measurements
por: Putterman, Chaim, et al.
Publicado: (2014)

Expression and function of inducible co-stimulator in patients with systemic lupus erythematosus: possible involvement in excessive interferon-γ and anti-double-stranded DNA antibody production
por: Kawamoto, Manabu, et al.
Publicado: (2006)

Epitope-Specific Anti-C1q Autoantibodies in Systemic Lupus Erythematosus
por: Kleer, Jessica S., et al.
Publicado: (2022)

Anti-Nuclear Antibodies Patterns in Patients With Systemic Lupus Erythematosus and Their Correlation With Other Diagnostic Immunological Parameters
por: Al-Mughales, Jamil A.
Publicado: (2022)

Elevated titers of anti-ribosomal-P antibodies in systemic lupus erythematosus
por: Zandman-Goddard, G, et al.
Publicado: (2005)

Anti-neutrophil cytoplasmic antibodies in new-onset systemic lupus erythematosus
por: Su, Fang, et al.
Publicado: (2017)

Anti-dsDNA antibodies in the classification criteria of systemic lupus erythematosus
por: Infantino, Maria, et al.
Publicado: (2021)

Correlation of Serum Soluble Interleukin-7 Receptor and Anti-C1q Antibody in Patients with Systemic Lupus Erythematosus
por: Chi, Shuhong, et al.
Publicado: (2016)

Clinicopathologic characteristics and outcomes of lupus nephritis with positive antineutrophil cytoplasmic antibody
por: Wang, Shuai, et al.
Publicado: (2020)

Anti-double stranded DNA antibodies: A rational diagnostic approach in limited-resource settings
por: Admou, Brahim, et al.
Publicado: (2022)

In reply to “Anti-alpha-enolase antibodies in membranous nephropathy: isotype matters”
por: Imai, Hirokazu, et al.
Publicado: (2016)

Development of Potential Pharmacodynamic and Diagnostic Markers for Anti-IFN-α Monoclonal Antibody Trials in Systemic Lupus Erythematosus
por: Yao, Yihong, et al.
Publicado: (2009)

The Usefulness of Endothelial Cell Adhesion Molecules and Anti-C1q Antibody in Monitoring Systemic Lupus Erythematosus Disease Activity
por: Mahayidin, Hasni, et al.
Publicado: (2014)

Specificity of anti-SSB as a diagnostic marker for the classification of systemic lupus erythematosus
por: RAO, LI, et al.
Publicado: (2013)

Association of anti-ribosomal P protein antibodies with neuropsychiatric systemic lupus erythematosus
por: Ambrozic, A, et al.
Publicado: (2004)

Anti-C reactive protein antibodies in Indian patients with systemic lupus erythematosus
por: Pradhan, V., et al.
Publicado: (2013)

Domain binding and isotype dictate the activity of anti-human OX40 antibodies
por: Griffiths, Jordana, et al.
Publicado: (2020)

Anti-tumor antibody isotype response can be modified with locally administered immunoadjuvants
por: Walters, Adam A., et al.
Publicado: (2022)

Anti-Cytokine Autoantibodies in Systemic Lupus Erythematosus
por: Howe, Hwee Siew, et al.
Publicado: (2019)

Anti-double Stranded DNA Antibodies: Origin, Pathogenicity, and Targeted Therapies
por: Wang, Xiaoyu, et al.
Publicado: (2019)

Anti-C1q Antibodies as Occurring in Systemic Lupus Erythematosus Could Be Induced by an Epstein-Barr Virus-Derived Antigenic Site
por: Csorba, Kinga, et al.
Publicado: (2019)

Efficiency of Disease and Disease Activity Diagnosis Models of Systemic Lupus Erythematosus Based on Protein Array Analysis
por: Zhao, Yafei, et al.
Publicado: (2022)

Lipid Anti-Lipid Antibody Responses Correlate with Disease Activity in Systemic Lupus Erythematosus
por: Jovanović, Vojislav, et al.
Publicado: (2013)

The Role of Anti-Phosphatidylserine/Prothrombin Antibodies in Thrombotic Manifestations of Systemic Lupus Erythematosus Patients
por: Tselios, Konstantinos, et al.
Publicado: (2013)

Anti-apolipoprotein A-I antibodies and paraoxonase 1 activity in Systemic Lupus Erythematosus
por: Ahmed, Mohammed Mahmoud, et al.
Publicado: (2013)

Clonal evolution and antigen recognition of anti-nuclear antibodies in acute systemic lupus erythematosus
por: Sakakibara, Shuhei, et al.
Publicado: (2017)

Study on the correlation between anti-ribosomal P protein antibody and systemic lupus erythematosus
por: Wang, Yanping, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_c0ij7oi9ppgenforv72ikomjgf